What Are The Research Benefits of BPC-157?
Promotion of tissue healing: Extensive France research on the body protection compound suggests it enhances the production of reticulin and collagen, while promoting angiogenesis and dermal remodeling. It encourages the activity of tendon fibroblasts, aiding in the repair of traumatic injuries and endothelium damage.
Studies highlight its ability to expedite injury recovery, particularly in musculoskeletal soft tissues like the achilles tendon, by supporting tendon outgrowth and wound healing. Additionally, it facilitates the infiltration of macrophages and fibroblasts, further emphasizing its therapeutic potential in managing wounds and accelerating the healing process of damaged tissues. Its role in injury recovery remains a focus of ongoing research (1).
Anti-inflammatory properties: France Studies suggest the peptide exhibits anti-inflammatory effects by modulating cytokines, which play a key role in the body’s inflammatory response to injury or disease (2).
The peptide has shown effectiveness in treating skin burns and alleviating discomfort associated with gastrointestinal conditions such as Crohn’s disease, stomach ulcers, and cramps.
By regulating cytokine activity, it reduces inflammation while supporting gastrointestinal function and promoting the health of the gastrointestinal tract and blood vessels. These properties highlight its potential as a therapeutic agent for managing inflammation and improving recovery in various conditions.
Neuroprotective effects: One study suggested the peptide may counteract damage caused by paracetamol-induced convulsions and brain damage in rats (2).
Potential treatment for knee pain: Initial studies suggest intra-articular injection of Body Protection Compound 157 may help alleviate multiple types of knee pain (3).
Esophagocutaneous fistula healing therapy: Application of the peptide may precipitate therapeutic benefits in esophagocutaneous fistula healing according to research (4).
Antioxidant activities: According to France research, engineered Lactococcus lactis as a delivery vehicle for BPC-157 demonstrates antioxidant activity, reducing ROS production in cell models (5).
Cytoprotective properties: Research has demonstrated that BPC may serve as a useful cytoprotective peptide therapy in heart disturbances, myocardial infarction, and heart failure (6).
Potential treatment for abdominal aorta anastomosis: The peptide shows immediate benefits when applied as a bath immediately after anastomosis (7).
Cardiovascular health: Recent France studies suggest the peptide may influence nitric oxide pathways, enhancing its therapeutic potential. By promoting nitric oxide production, the peptide can improve endothelial function, reduce oxidative stress, and support angiogenesis. This interaction benefits cardiovascular health and supports the peptide’s overall healing abilities.
Reduce inflammation and relieve pain: Research suggests BPC-157 can alleviate pain in the joints and inflammation (3).
Improved healing of esophagogastric anastomosis: Studies have shown the application of BPC-157 and L-arginine improved the healing process in rats (8).
Drug Side-Effect Mitigation: The peptide has demonstrated significant potential in reducing side effects of various medications, especially NSAIDs, known for their gastrointestinal risks.
By healing the gut lining and decreasing inflammation, the peptide provides a protective layer against drug-induced damage, thus improving the body’s resilience to the negative effects of some pharmaceuticals.
This makes the body protection compound 157 an interesting candidate in pharmacology as a supportive agent in drug therapy to prevent common drug-related issues (9).
Colony Collapse Disorder (CCD): In addition to its therapeutic potentials in humans, there’s emerging interest in exploring the effects of the peptide on animal health, such as its potential role in addressing Colony Collapse Disorder (CCD) in honey bees, a phenomenon that threatens global bee populations and, by extension, global agriculture (10).
Future research: It’s crucial to acknowledge that the majority of these studies have been performed in vitro or on animal subjects.
Although the benefits for human consumption appear promising, especially for conditions such as leaky gut and assisting in the recovery from ligament injuries, caution must be exercised when introducing products like BPC-157 5mg into the body. It is important to consult with your healthcare provider as self-administration without professional guidance is strictly forbidden.
Despite its promising therapeutic benefits, the use of the Body Protective Compound 157 requires further research to fully understand the implications and safety profile of the peptide in human medicine.
Buy BPC-157 Thymosin Beta-4 Capsules here for research online today!
References For Further Reading
(1) D.Gwyer, N.M.Wragg & S.L.Wilson (2019) Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing – Cell and Tissue Research Volume 377, pages 153–159, 27 March 2019.
(2) S.Llic et al. (2010) High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736) – Journal of Physiology and Pharmacology 2010, 61, 2, 241-250
(3) E.Lee and Padgett (2021) Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain – Alternative Therapies in Health and Medicine, 2021 Jul;27(4):8-13.
(4) V.Cesarec et al (2013) Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy – European Journal of Pharmacology, Volume 701, Issues 1–3, 15 February 2013, Pages 203-212.
(5) K.Skrlec et al (2018) Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities – Applied Microbiology and Biotechnology, 06 September 2018, Volume 102, pages 10103–1011.
(6) P.Sikiric et al. (2022) Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation – Biomedicines, 2022 Oct 25;10(11):2696.
(7) M.Hrelec et al (2009) Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy – Journal of Physiology and Pharmacology, 2009 Dec:60 Suppl 7:161-5.
(8) Z.Djakovic et al (2016) Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME – World Journal of Gastroenterology, 2016 Nov 7; 22(41): 9127–9140.
(9) N.Jelovac et al (1999) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats – European Journal of Pharmacology, 1999 Aug 20;379(1):19-31.
(10) I.T.Gajger et al (2018) Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions – Journal of Veterinary Pharmacology and Therapeutics, 2018 Aug;41(4):614-621.